Direkt zum Inhalt

Schaber, Katharina ; Leitzmann, Michael ; Pukrop, Tobias ; Quentin, Wilm ; Stein, Michael J. ; Jochem, Carmen

Burden of cancer attributable to sedentary behaviour in Germany: an epidemiological analysis of survey data

Schaber, Katharina, Leitzmann, Michael , Pukrop, Tobias , Quentin, Wilm, Stein, Michael J. und Jochem, Carmen (2025) Burden of cancer attributable to sedentary behaviour in Germany: an epidemiological analysis of survey data. BMJ Open 15 (1), e094304.

Veröffentlichungsdatum dieses Volltextes: 23 Jan 2025 10:13
Artikel
DOI zum Zitieren dieses Dokuments: 10.5283/epub.74741


Zusammenfassung

Objectives Sedentary behaviour (SB) is associated with increased risks of breast, colorectal, endometrial, ovarian and rectal cancers. However, the number of cancer cases attributable to SB in Germany and the associated costs are unknown. Setting Numbers and proportions (population-attributable fractions, PAF) of new cancer cases attributable to SB with published risk estimates for Germany for ...

Objectives Sedentary behaviour (SB) is associated with increased risks of breast, colorectal, endometrial, ovarian and rectal cancers. However, the number of cancer cases attributable to SB in Germany and the associated costs are unknown.

Setting Numbers and proportions (population-attributable fractions, PAF) of new cancer cases attributable to SB with published risk estimates for Germany for the years 2024, 2030 and 2040.

Participants Sex-specific and age-specific population projections, national cancer incidence and exposure data. Primary and secondary outcome measures: new cancer cases attributable to SB and healthcare costs associated with cancer cases attributable to SB in Germany for the year 2024.

Results Estimated numbers of cancers attributable to SB are projected to be up to 7612 cases (6% of total cancer cases) in 2024, up to 7899 cases (6%) in 2030 and up to 8245 cases (6%) in 2040. The PAF attributable to SB in women is 3% for breast cancer, 8% for colon cancer, 9% for both endometrial and ovarian cancers and 2% for rectal cancer. In men, the PAF is 9% for colon cancer and 3% for rectal cancer. In 2024, the estimated costs of SB-attributable cancers are €270 million for colon cancer, €51 million for rectal cancer, €234 million for breast cancer and €242 million for female genital cancers.

Conclusions A considerable number of cancer cases can be attributed to SB, which also imposes a large health economic burden. Implementing effective prevention measures, such as workplace, school or commuting interventions, is needed to reduce the incidence of cancer attributable to this modifiable risk factor.



Beteiligte Einrichtungen


Details

DokumentenartArtikel
Titel eines Journals oder einer ZeitschriftBMJ Open
Verlag:BMJ
Band:15
Nummer des Zeitschriftenheftes oder des Kapitels:1
Seitenbereich:e094304
Datum14 Januar 2025
InstitutionenMedizin > Institut für Epidemiologie und Präventivmedizin
Identifikationsnummer
WertTyp
10.1136/bmjopen-2024-094304DOI
Dewey-Dezimal-Klassifikation600 Technik, Medizin, angewandte Wissenschaften > 610 Medizin
StatusVeröffentlicht
BegutachtetJa, diese Version wurde begutachtet
An der Universität Regensburg entstandenJa
URN der UB Regensburgurn:nbn:de:bvb:355-epub-747418
Dokumenten-ID74741

Bibliographische Daten exportieren

Nur für Besitzer und Autoren: Kontrollseite des Eintrags

nach oben